| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Chief Discovery/ Trans Medicine | Senior Vice President
1 company
Hamilton James C is a Chief Medical Officer at Arrowhead Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 19 sells.
Estimated insider holdings value: $18.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 23, 2026 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Medical Officer | Sell | 10,000 | $75.00 | $750,000.00 | -4.2% | - | - | |
| Mar 5, 2026 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Medical Officer | Sell | 10,000 | $64.19 | $641,900.00 | -4.0% | +14.1% | - | |
| Jan 5, 2026 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Medical Officer | Sell | 40,164 | $63.11 | $2,534,661.46 | -3.0% | -4.3% | - | |
| Oct 1, 2025 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Medical Officer | Sell | 20,000 | $35.00 | $700,000.00 | -8.6% | +92.1% | - | |
| Sep 12, 2025 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Medical Officer | Sell | 15,000 | $30.00 | $450,000.00 | -6.1% | +138.3% | - | |
| Sep 2, 2025 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Medical Officer | Sell | 15,000 | $25.00 | $375,000.00 | -5.7% | +119.0% | - | |
| Aug 15, 2025 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Medical Officer | Sell | 10,000 | $20.00 | $200,000.00 | -1.8% | +100.6% | - | |
| Jan 6, 2025 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Discovery/ Trans Medicine | Sell | 32,729 | $19.82 | $648,824.25 | -5.6% | -47.4% | +263.1% | |
| Apr 1, 2024 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Discovery/ Trans Medicine | Sell | 6,000 | $28.03 | $168,180.00 | -2.8% | -7.8% | -56.8% | |
| Jan 12, 2024 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Discovery/ Trans Medicine | Sell | 7,940 | $36.89 | $292,903.60 | -1.8% | -29.5% | -49.2% |